Method for evaluating compounds effective for treatment of obesity with Slc25a10

摘要

In the evaluation of a compound such as screening for a therapeutic drug for obesity, the evaluation is performed using the expression level of the Slc25a10 gene or protein in a test tissue or test cell and the properties of the gene or protein. In the test for obesity, a test based on the expression level of the Slc25a10 gene, the polymorphism in the gene, and the like is performed.